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Abstract 
Capsaicin is a new naturally occurring inhibitor of proton-pumping NADH-ubiquinone oxidoreductase (NDH-1), that competitively 
acts against ubiquinone. A series of capsaicin analogues was synthesized to examine the structural factors required for the inhibitory 
action and to probe the structural property of the ubiquinone catalytic site of various NADH-ubiquinone reductases, including 
non-proton-pumping enzyme (NDH-2), from bovine heart mitochondria, potato tuber (Solanum tuberosum, L) mitochondria nd 
Escherichia coli (GR 19N) plasma membranes. Some synthetic apsaicins were fairly potent inhibitors of each of the three NDH-I 
compared with the potent rotenone and piericidin A. Synthetic apsaicin analogues inhibited all three NDH-1 activities in a competitive 
manner against an exogenous quinone. The modification both of the substitution pattern and of the number of methoxy groups on the 
benzene ring, which may be superimposable on the quinone ring of ubiquinone, did not drastically affect the inhibitory potency. In 
addition, alteration of the position of dipolar amide bond unit in the molecule and chemical modifications of this unit did not change the 
inhibitory potency, particularly with bovine heart and potato tuber NDH-1. These results might be explained assuming that the ubiquinone 
catalytic site of NDH- 1 is spacious enough to accommodate a variety of structurally different capsaicin analogues in a dissimilar manner. 
Regarding the moiety corresponding to the alkyl side chain, a rigid diphenyl ether structure was more inhibitory than a flexible alkyl 
chain. Structure-activity studies and molecular orbital calculations suggested that a bent form is the active conformation of capsaicin 
analogues. On the other hand, poor correlations between the inhibitory potencies determined with the three NDH-I suggested that the 
structural similarity of the ubiquinone catalytic sites of these enzymes is rather poor. The sensitivity to the inhibition by synthetic 
capsaicins remarkably differed between NDH-1 and NDH-2, supporting the notion that the sensitivity against capsaicin inhibition 
correlates well with the presence of an energy coupling site in the enzyme (Yagi, T. (1990) Arch. Biochem. Biophys. 281,305-311). It is 
noteworthy that several synthetic apsaicins discriminated between NDH-I and NDH-2 much better than natural capsaicin. 
Keywords." NADH-ubiquinone reductase; Capsaicin; Structure-activity relationship 
I. Introduction 
Rotenone and piericidin A are well-known, naturally 
occurring potent inhibitors of NADH-ubiquinone oxido- 
reductase, acting at, or close to, the ubiquinone catalytic 
site [1,2]. These inhibitors have been widely used to probe 
the mechanistic oncepts and structural aspects of this 
protein complex [3-5]. The new naturally occurring in- 
Abbreviations: NDH, NADH-ubiquinone oxidoreductase; NDH-1, 
NDH that bears an energy coupling site; NDH-2, NDH that lacks an 
energy coupling site; DB, 2,3-dimethoxy-5-methyl-6-n-decyl-l,4-benzo- 
quinone; deaminoNADH, reduced nicotinamide hypoxanthine dinucleo- 
tide. 
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hibitor, capsaicin (Fig. 1), the pungent principle of red 
pepper species, has been shown to act as a competitive 
inhibitor for ubiquinone with NADH-ubiquinone oxido- 
reductase isolated from bovine heart mitochondria [6]. 
Using submitochondrial particles prepared from bovine 
heart mitochondria nd several bacterial membranes, Yagi 
[7] has demonstrated that the inhibition of NADH- 
ubiquinone oxidoreductase activities of several organisms 
by capsaicin correlated well with the presence of an energy 
coupling site in this segment of the respiratory chain. That 
is, the sensitivity to capsaicin inhibition of NADH- 
ubiquinone oxidoreductase that bears an energy coupling 
site (NDH-1) is much higher than that of the enzyme that 
lacks an energy coupling site (NDH-2). Yagi consequently 
concluded that capsaicin inhibition correlates better with 
the presence of a coupling site than that by rotenone, 
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Fig. 1. Structure ofnatural capsaicin. Capsaicin ssplit into three sections 
(A, B and C) for simplicity. 
We investigated their ability to inhibit NDH-1 as well as 
NDH-2 from bovine heart mitochondria, potato tuber mito- 
chondria nd E. coli plasma membranes, and compared it
with that of potent inhibitors such as rotenone and pieri- 
cidin A. 
2. Experimental procedures 
piericidin A or DCCD (N,N'-dicyclohexylcarbodiimide) 
[7], which had been thought to discriminate fairly well 
between NDH-I and NDH-2 [8]. Thus capsaicin appeared 
to be a useful reagent for investigating the mechanism of 
an energy coupling site associated with NADH-ubiquinone 
oxidoreductase. 
To examine the mode of action of capsaicin and to 
probe the structural property of its binding site which 
might overlap the ubiquinone binding site, identification of 
the structural factors of this inhibitor required for the 
inhibition is essential. The structural requirements of cap- 
saicin analogues for other pharmacological effects, such as 
analgesic activity have been examined closely (for exam- 
ple, Refs. [9,10]), whereas structure-activity studies of 
capsaicin analogues regarding electron-transfer inhibition 
have been reported only twice [6,11], to our knowledge. 
Chudapongse and Janthasoot [11] found that methyl cap- 
saicin is several times more potent han natural capsaicin, 
indicating that the phenolic OH group is not essential for 
the activity. On the other hand, Shimomura et al. [6] have 
shown that capsaicin analogues with an acyl group of l0 to 
12 carbons are much more potent han capsaicin, indicat- 
ing that the hydrophobicity of the acyl moiety favors the 
activity. However, the structural variations of capsaicin 
analogues in these studies seemed insufficient o evaluate 
details of the structural factors required for the inhibitory 
action or to probe the structure of their binding sites. For 
instance, the roles of the substitution pattern of methoxy 
groups on the benzene ring, which may be superimposable 
on the ubiquinone ring, and of the amide bond unit in the 
inhibitory action have not been defined. Furthermore, con- 
sidering that natural capsaicin is not necessarily a potent 
inhibitor of NDH-1 compared to the potent one such as 
rotenone and piericidin A [7], the development of the 
potent synthetic apsaicin analogues that possess a strictly 
selective activity for either NDH-1 or NDH-2 would be 
highly useful. 
The prototype capsaicin has been split into three sec- 
tions for simplicity as follows: the substituted benzene ring 
(A-section), the dipolar amide bond region (B-section) and 
the hydrophobic side chain (C-section), as shown in Fig. 1. 
In this study, we synthesized 49 capsaicin analogues by 
modifying each region in isolation. It was of interest o 
compare the effects of various synthetic apsaicin ana- 
logues on NDH-1 and NDH-2 activities, the latter being 
supposedly insensitive to inhibition by natural capsaicin. 
2.1. Materials 
NADH, deaminoNADH (reduced nicotinamide hypox- 
anthine dinucleotide), antimycin A, capsaicin and HQNO 
(heptylhydroxyquinoline N-oxide) were purchased from 
Sigma. Rotenone was obtained from Tokyo Chemical In- 
dustry Co. DB (2,3-dimethoxy-5-methyl-6-n-decyl-l,4- 
benzoquinone) was the same sample as described [12]. 
Piericidin A was a generous gift from Dr. Shigeo Yoshida 
(The Institute of Physical and Chemical Research (RIKEN), 
Japan). Fenpyroximate (tert-butyl-a-(l,3-dimethyl-5-phe- 
noxypyrazol-4-ylmethyleneaminooxy)-p-toluate) was syn- 
thesized as reported [13]. 
2.2. Synthesis 
The structures of capsaicin analogues ynthesized here 
are shown in Fig. 2. All compounds were prepared by 
condensation of the corresponding amines and acid chlo- 
rides in the presence of triethylamine in dichloromethane 
or sodium carbonate in water/dichloromethane (0.8:1.0, 
v /v)  at 4°C (Scheme 1, reactions 1and 2). The substituted 
benzylamines (the precursors of series I, IV, V and VI 
compounds) were synthesized by reduction with LiAlH 4 in 
dry ether [14] from corresponding substituted benzonitriles 
(Scheme I, reaction 3), which were obtained from corre- 
sponding commercially available substituted benzaldehy- 
des in the presence of NHzOH-HC1 and sodium acetate in 
acetic acid at 130°C [ 15]. 3,4-Dimethoxyaniline (precursor 
of compound 15) and 3,4-dimethoxyphenethylamine (the 
precursor of compound 16) were commercially available. 
2-(3,4-Dimethoxybenzyl)ethylamines (th  precursors of 
compound 17) was prepared by reducing with LiAIH 4 of 
3,4-dimethoxypenethylnitrile, which was synthesized by 
reacting of 3,4-dimethoxypenethylbromide an  sodium 
cyanide in dimethylsulfoxide at 100°C. 3,4-Dimethoxy- 
benzoic acid (the precursor of compound 18), 3,4-di- 
methoxyphenylacetic acid (the precursor of 19) and 3,4-di- 
methoxylphenetyl acid (the precursor of compound 20) 
were also commercially available. 4-(Substituted phen- 
oxy)benzoylchlorides (the precursors of series V com- 
pounds) were prepared by reacting in dimethylformamide 
of thionylchloride and corresponding methyl 4-(substituted 
phenoxy)benzoates, which were synthesized from methyl 
4-bromobenzoate and corresponding commercially avail- 
able substituted phenols in the presence of potassium 
carbonate and copper [16]. The substituted benzoylchlo- 
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4: 2,4-(MEO)2 11: 3,4-(Me)2 37: 4-C(CH3) 3 
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6: 3,5-(MEO)2 13: 3,4-(-OCH20-) 39: 4-CHzC6H 5
7: 2-MeO 14: 3,4-CI 2 40: 4-C(CH3)2CH2CH 3 
Series II O 2,5-(MEO)2- 
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25: 4-(CH2)3CH 3 OMe 0 
26: 4-(CH2)7CH 3 ~ " ~  
27: 4-C6H 5 N 
28: 4-O(CH2)6CH 3 (CH2)TCH3 
29: 3-O(CH2)eCH 3 OMe 49 
30: 2-OH-4-(XCH2)sCH3 
31: 4-O(CH2)9CH 3 
32: 4-OCH2CsH5 
33: 2,3-(-CH=CH-CH=CH-) 
34: 3,4-(-CH=CH-CH=CH-) 
Fig. 2. Structures of all capsaicin analogues synthesized in the present s udy. 
Reaction 1 O 
Xo-2 (n = 0-3) Xo-2 
Reaction 2 
~(CH2)n~C'+ CH,(CH2)IIonNH2 8 or b I~ J y (cH2)I1-nCH  `
XI-2 (n - 0-2) X1-2 
Reaction 3 
xo-2 Xo-2 Xo-2 
Scheme 1. Reaction conditions. (a) Et3N/CH2C12; (b) K2CO3/H20/CHTCI2;  (c) NH2OH-HCI/CH3COONa / CH3COOH/A; (d) LiAIH4/Et20. 
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rides (the precursors of series IV compounds) were ob- 
tained by reacting of thionylchloride and corresponding 
commercially available substituted benzoic acids in the 
presence of dimethylformamide in dichloromethane at 
40°C. Compounds 42, 43, 44 and 45 were obtained by 
N-methylation of compounds 2, 5, 37 and 26, respectively, 
with methyl iodide in the presence of triethylamine and 
sodium hydride in dimethylsulfoxide. Compounds 46 and 
47 were synthesized by reducing 37 and 2, respectively, 
with LiA1H 4 in tetrahydrofuran. 6,7-Dimethoxy-l,2,3,4-te- 
trahydroisoquinoline (the precursor of compound 48) was 
commercially available. 
All synthesized compounds were characterized by J H- 
NMR spectra (JEOL PMX-60) and elemental analyses for 
C, H and N within an error of _+ 0.3%. 
2.3. Methods 
Bovine heart submitochondrial particles were prepared 
by the method of Matsuno-Yagi and Hatefi [17]. NADH- 
DB reductase activity was measured using a stirred cuvette 
in a Shimadzu UV3000 spectrophotometer at 30°C, as the 
rate of NADH oxidation (340 nm, e = 6.2 mM ~ cm ~). 
The reaction medium, in a final volume of 2.5 ml, con- 
tained 50 mM potassium phosphate (pH 7.4), 0.25 M 
sucrose, 1 mM MgCI2, 2 mM KCN, 0.4/zM antimycin A 
and 50 /zM DB, the final mitochondrial protein concentra- 
tion being 15 /xg/mi. The enzyme reaction was started by 
the addition of 50 /xM NADH. 
Membranes of E. coli (GRI9N) were prepared as de- 
scribed [18] and were a gift from Dr. K. Matsushita 
(Yamaguchi University, Japan). The deaminoNADH-DB 
reductase activity of NDH-1 was measured as described 
[12] in reaction medium containing 50 mM phosphate 
buffer (pH 7.4), 2.5 mM KCN, 5 mM MgSO 4 and 10 /xM 
DB, the final protein concentration being 15 /xg/ ml. The 
enzyme reaction was started by adding 50 /zM deaminoN- 
ADH. The activity of NDH-2 was determined by the same 
method as that for the NDH-1 assay, except 50 /zM 
NADH (plus 5 /zM compound 39) was added in place of 
deaminoNADH. We used compound 39 to selecti~ely 
inhibit NDH-1 activity, because it is a far more potent 
inhibitor of NDH-I than rotenone (see Results). 
Potato tuber (Solanum tuberosum, L) submitochondrial 
particles were prepared according to MOller et al. [19]. The 
deaminoNADH-DB reductase activity of NDH- 1 was mea- 
sured as described [12] in a reaction medium consisting of 
50 mM phosphate buffer (pH 7.4), 0.25 M sucrose, 2 mM 
KCN, 1 mM MgCI 2, 2 /~M antimycin A and 40 /zM DB, 
the final protein concentration being 15 /xg/ml. The en- 
zyme reaction was started by the addition of 80 /zM 
deaminoNADH. The activity of NDH-2 located inside the 
inner membrane was measured using 80 /~M NADH (plus 
100 /zM rotenone and 0.2 mM EGTA) instead of 
deaminoNADH. In all assays, the inhibitor was incubated 
for 4 min in advance of the reaction. 
The stable conformation of synthetic capsaicins was 
studied by molecular orbital methods. Computations were 
achieved using a semi-empirical molecular orbital program 
package (MOPAC ver. 6.01) with AM1 parameterization 
[20]. Initial conformations were constructed using standard 
bond lengths and angles. 
3. Results 
3.1. Assays with bovine heart mitochondrial NDH 
The inhibitory potencies of all synthetic apsaicin ana- 
logues for NADH-DB reductase activity are listed in Table 
1. The p150, the logarithm of the reciprocal of /50 which is 
the molar concentration i  the reaction medium required to 
halve the control enzyme activity, was used as the index of 
inhibitory potency. The p150 measurement was repeated at 
least twice and the result was averaged. The standard 
inhibitors were natural capsaicin, rotenone, piericidin A, 
HQNO and fenpyroximate, which is a new synthetic pesti- 
cide acting upon mitochondrial NADH-ubiquinone oxido- 
reductase [13,21]. Almost all synthetic capsaicins were 
more potent han natural capsaicin. 
The 3- and 4-positions of the benzene ring of natural 
capsaicin are substituted by methoxy and hydroxy groups, 
respectively. Chudapongse and Janthasoot [11] showed that 
the 4-hydroxy group is not essential for the activity, and 
can be replaced with a methoxy group. Shimomura et al. 
[6] have demonstrated that capsaicin analogues with acyl 
groups of 10 to 12 carbons are more potent than natural 
capsaicin. Considering these findings, we synthesized se- 
ries I compounds to examine whether a 3,4-dimethoxy 
substitution pattern is important for the activity; in other 
words, whether these methoxy groups are strictly recog- 
nized by the binding site. Looking at the variation of 
inhibitory potencies of series I compounds from this per- 
spective (Table 1), it is clear that 3,4-dimethoxy substitu- 
tion pattern is not necessarily essential for the activity, 
since inhibitors possessing other substitutions including 
monomethoxy substitution retained the activity. Replacing 
the methoxy group by methyl or chloride resulted in a 
decrease in the activity (2 vs. 11 or 14, and 5 vs. 10), 
indicating that existence of the methoxy group itself is 
important for the activity, whereas its substitution pattern 
is not limited. 
The dipolar amide bond (-NHCO-), which can act as a 
hydrogen-bond donor and acceptor, is linked to benzene 
ring through one methylene unit for natural capsaicin. It 
was of interest o examine whether the relative position of 
the amide bond unit and the benzene ring is strictly 
recognized by the binding site. We therefore synthesized 
the series II and III compounds. The hydrophobicity of the 
derivatives was standardized by fixing the number of total 
methylene units to a total of 13 carbons. Except for the 
derivatives of n = 0 (compounds 15 and 18), the relative 
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Table 1 
Inhibit ion of  var ious NDH act iv it ies by synthetic apsaicin analogues 
Bov ine  SMP Potato SMP E. coli 
Compd. NDH-1 plso NDH-1 Pls0 NDH-2  a inhibi t ion(%) b NDH-1 plso NDH-2 inhib i t ion(%) b
1 4.66 4.92 _ c < 4 d _ 
2 5.00 4.43 n.t. 4.30 - 
3 5.11 4.00 - <4 - 
4 4.59 5.05 - 5.40 - 
5 5.30 5.00 100 < 4 - 
6 < 4 4.92 - 5.30 - 
7 4.00 4.52 - 4.10 - 
8 4.90 4.00 60 4.08 - 
9 4.42 4.80 100 4.59 80 
10 < 4 4.52 - 4.00 60 
11 < 4 4.66 - 4.00 60 
12 5.20 - - < 4 70 
13 4.58 4.90 - 4.20 60 
14 3.78 4.74 - 4.15 70 
15 < 4 4.90 - < 4 - 
16 5.26 4.46 - < 4 - 
17  4 .60  - - < 4 40 
18 <4 5.00 - <4 - 
19 5.75 4.80 - 4.52 - 
20 5.20 4.52 - 4.77 40 
21 3.44 - - 5.10 - 
22 3.85 3.52 - 5.30 - 
23 3.52 - - < 4 - 
24 5.06 - - 5.71 - 
25 5.22 - - 6.74 
26 5.54 5.30 - 6.82 50 
27 < 4 5.40 - 6.15 - 
28 5.49 4.86 - 6.30 60 
29 5.43 4.89 - 4.70 60 
30 5.22 5.28 30 5.30 90 
31 4.87 - - 5.82 70 
32 5.44 - - < 4 - 
33 4.10 4.15 - < 4 - 
34 4.99 4.43 - 5.72 - 
35 5.77 - n.t. 5.30 90 
36 5.96 - - 6.35 - 
37 7.03 5.50 100 6.72 60 
38 5.63 5.40 - 6.60 60 
39 5.78 5.15 - 7.00 50 
40 6.78 5.62 n.t. 7.00 60 
41 6.38 5.56 n.t. 4.46 60 
42 5.49 4.52 n.t. 4.00 - 
43 5.45 3.92 n.t. 4.30 30 
44 7.12 5.27 - 5.70 40 
45 5.59 5.00 n.t. 4.70 60 
46 6.92 5.01 - 5.58 60 
47 5.40 4.00 n.t. 4.96 - 
48 5.74 4.74 n.t. 4.03 - 
49 5.20 4.60 n.t. 5.26 60 
Capsaic in 4.28 3.87 - 4.77 20 
Rotenone 7.59 5.30 - 4.90 70 
Pier ic idin 8.22 7.82 n.t. 6.63 50 
Fenpyrox. 7.74 6.26 n.t. 5.00 60 
HQNO < 4 < 4 n.t. 5.15 80 
The inhibit ion of  NADH (or deaminoNADH) -DB reductase activity was determined, as described in Exper imental  procedures. (a) NDH-2  located inside 
the inner mitochondr ia l  membrane was assayed. (b) The relat ive inhibit ion (%) in the presence of  100 /xM inhibitor is shown. (c) Compounds  that did not 
el icit  inhibit ion at 100 /xM are marked by .....  . (d) Compounds  that did not attain 50% inhibit ion at 100 /xM are marked by " < 4" .  The effects of  h igher 
concentrat ions were not studied due to l imited solubi l i ty.  
n.t., not tested; Fenpyrox,  Fenpyroximate.  
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position of the amide bond unit and benzene ring as well 
as the order of NH and CO (-NHCO- or -CONH-) ap- 
peared not to significantly affect the activity. Moreover, 
N-methylation of amide bond retained or rather potentiated 
the activity (2 vs. 41, 5 vs. 43, 37 vs. 44, and 26 vs. 45). 
These observations indicated that the existence of a dipolar 
amide bond itself and its spatial distance from the benzene 
ring contribute relatively little to the inhibitor binding. 
To understand the roles of the alkyl side chain of 
capsaicin, we synthesized series IV and V compounds. The 
hydrophobic and rigid diphenyl ether structure tended to 
favor the activity. Elongation of the side chain beyond that 
of compound 37 (tert-butyl group) decreased the activity 
(37 vs. 38, 39 or 40). The structural modifications of 
potent inhibitor compound 37 confirmed the above conclu- 
sions about the roles of the A- and B-sections in the 
inhibition. That is, the fact that compounds 41, 44 and 46 
retained the inhibitory potency compared to compound 37 
indicated that an amide bond unit and a 3,4-dimethoxy 
substitution are not necessarily important for the activity. 
Next, we examined the kinetics of the inhibition of 
NADH-DB reductase by some compounds. Fig. 3 shows 
double-reciprocal plots demonstrating the effect of a fixed 
concentration of compound 37 on the rate of NADH-DB 
reductase activity. The double-reciprocal plots were curvi- 
linear in the presence of a fixed concentration of com- 
pound 37. In the lower concentration range of DB, com- 
pound 37 appeared to be a noncompetitive inhibitor. At 
higher concentrations of DB, compound 37 acted as a 
competitive inhibitor egarding DB. Compounds 44 and 46 
had similar inhibition profiles (data not shown). 
Yagi [7] has shown that the 150 values of natural 
capsaicin for the inhibition of NADH oxidase activity of 
bovine submitochondriai particles and Paracocus mem- 
branes decrease as the pH increases. Based upon the pH 
profile of the /50 values, Yagi suggested that the ionic 
compound 37 (nM) 
20 
'= ,, S t```  " "  • 
-g 
j j s  ~ 0 
°0.6 -0.4 -0.2 0 0.2 0.4 
1/DB (~VI "1) 
Fig. 3. Double-reciprocal plots of kinetic data of NADH-DB reductase in 
bovine heart submitochondrial particles in the presence of compound 37. 
The reaction medium, in a final volume 2,5 ml, contained 50 mM 
potassium phosphate (pH 7.4), 0.25 M sucrose, 1 mM MgC12, 2 mM 
KCN, 0.4/xM antimycin A and 50 /zM NADH. The final mitochondrial 
protein concentration was 15 /xg/ml. 
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Fig. 4. The effect of pH on the NADH oxidase activity of bovine 
submitochondrial particles ((D) and its inhibition by compound 37 (0) .  
The pH values of the buffer containing 50 mM potassium phosphate, 0.25 
M sucrose and 1 mM MgCI 2 were adjusted by adding HC1. The NADH 
concentration was 50 txM. 
residue(s) with a pK a about 7.5 is involved in the inhibi- 
tion by capsaicin. To confirm this for synthetic derivatives, 
we examined the pH dependence of the inhibition of 
NADH oxidase activity of bovine submitochondrial parti- 
cles by potent synthetic capsaicin (compound 37). As 
shown in Fig. 4, the optimum pH for NADH oxidase 
activity was around 7.5. The pH profile of plso was 
similar to that reported by Yagi, suggesting that the ionic 
residue(s) involved in natural capsaicin inhibition is also 
involved in the inhibition by synthetic apsaicins. About 5 
to 10-fold lower 150 values were obtained in NADH 
oxidase assay compared with that measured in NADH-DB 
reductase assay, as reported [1,21]. 
Natural capsaicin does not inhibit succinate oxidase 
activity of rat liver mitochondria [l 1]. To confirm this for 
synthetic derivatives, we investigated the effect of syn- 
thetic capsaicins on succinate oxidase activity of bovine 
heart submitochondrial particles. Although some com- 
pounds partially inhibited succinate oxidase activity at 
high concentrations close to solubility limit, they did not 
elicit inhibition at the concentration range wherein they 
inhibit NADH-DB reductase activity. 
3.2. Assays with potato tuber mitochondrial NDH 
We next examined variations of the inhibitory potency 
depending upon structural modifications with potato tuber 
mitochondrial NDH-1 (Table 1). The variation in the activ- 
ity was somewhat smaller than that of bovine heart mito- 
chondrial NDH. The most potent inhibitor was compound 
40, the activity of which was comparable with that of 
rotenone. Like bovine heart mitochondrial NDH, both the 
3,4-dimethoxy substitution pattern and the relative position 
of the amide bond unit were not necessarily important for 
the activity. Contrary to bovine enzyme, the activity was 
almost totally retained when the methoxy group was re- 
placed with a methyl or chloride group (2 vs. 11 or 14, and 
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5 vs. ! 0). The difference in the inhibitory potency between 
flexible alkyl derivatives and rigid diphenyl ether deriva- 
tives was somewhat reduced compared to that of bovine 
heart mitochondrial NDH. The pattern of inhibition by 
compounds 37 and 40 was investigated using DB as an 
electron acceptor. These compounds inhibited the enzyme 
activity in a competitive manner against exogenous quinone 
(DB) regardless of its concentrations (data not shown). 
Two species of NADH-ubiquinone reductases are lo- 
cated on the inner surface of the inner membrane. One of 
them lacks an energy coupling site (NDH-2) and is insensi- 
tive to the inhibition by rotenone or piericidin A [22]. The 
inhibition of NDH-2 by synthetic capsaicins was also 
investigated. The relative inhibition (%) in the presence of 
100/~M of each compound was shown in Table 1. This 
concentration was nearly at the solubility limit of almost 
all tested compounds. Although compounds 5, 9 and 37 
were fairly potent inhibitors of NDH-2, the structural 
factors required for the inhibition could not be identified, 
since few compounds inhibited this enzyme. It was never- 
theless apparent hat the sensitivity to the inhibition by 
capsaicin analogues i remarkably different between NDH- 
1 and NDH-2. 
3.3. Assays with Escherichia coli NDH 
The inhibition of E. coli NDH-1 by synthetic cap- 
saicins was also examined (Table 1). Like the two proton- 
pumping NDH described above, a clear rule governing the 
inhibitory potency depending upon structural modifications 
of the A- and B-sections was not defined. However, 
structural modifications of the potent inhibitors (com- 
pounds 26 and 37) indicated that the roles of 3,4-di- 
methoxy group and amide bond unit in the activity are 
more important than those in the inhibition of bovine heart 
and potato tuber mitochondrial NDH-1 (26 vs. 45 or 49, 
and 37 vs. 41, 44 or 46). 
Compounds 39 and 40 potently inhibited NDH-1, even 
compared with piericidin A, which is one of the most 
potent inhibitors of this enzyme [21]. The inhibitory poten- 
cies of these compounds differed remarkably (by two to 
three orders of magnitude) between NDH-1 and NDH-2. 
Natural capsaicin also selectively inhibited NDH-1 activ- 
ity, being consistent with an earlier report [7], whereas the 
inhibitory potency was much less than that of the above 
potent synthetic derivatives. Considering both the in- 
hibitory potency for NDH-1 and the negligibly small effect 
on NDH-2 activity, we concluded that compounds 25 and 
36 are more selective inhibitors of NDH-1 than those 
known to date. Although some compounds inhibited NDH- 
2 at high concentrations, NDH-1 and NDH-2 have remark- 
ably different sensitivities to inhibition by capsaicin ana- 
logues, as observed with potato tuber mitochondrial en- 
zymes. The inhibition by compounds 39 and 40 of NDH-I 
was competitive against DB regardless of its concentration 
(data not shown). 
0 
Compound A 
o 
03. o2 II o, 
Compound B 
Fig. 5. Structure of compounds A and B. The compounds were rotated 
along 0j and 03 in steps of 120 ° and along 02 in steps of 60 °, and the 
amide bond was fixed in the trans conformation. 
3.4. Conformational study of capsaicin analogues 
The structure-activity study suggested that strict elec- 
trostatic interactions between the functional groups on 
capsaicins (i.e., vicinal methoxy groups and amide bond 
unit) and their binding site make relatively small contribu- 
tions to the inhibitor binding, in particular with bovine 
heart and potato tuber mitochondrial NDH-1. Therefore, it 
seems likely that the whole molecular shape plays an 
important part in the inhibitor binding. To obtain informa- 
tion on the active conformation of capsaicin analogues, we 
performed a conformational energy study upon compounds 
A and B (Fig. 5), which are simplified models of series 
IV-V compounds and their N-methyl derivatives, respec- 
tively. Compound A was rotated along 0j and 03 in steps 
of 120 ° and along 02 in steps of 60 ° and NH-CO bond was 
fixed in the trans conformation. The total energy of the 
molecule was calculated for each of 54 conformations. Six 
stable conformations existed within an energy difference in 
about 1 kcal mol- 1 arising from a difference in 02 and 03. 
In each conformation, the carbonyl plane was coplanar to 
that of the attached benzene ring and the two benzene ring 
planes were almost perpendicular to each other. 
Although the total energy was increased for each of the 
six stable conformations of compound B due to steric 
congestion by N-methylation, the same conclusion about 
the conformation was derived; namely, the molecule is 
stable when the two benzene ring planes are almost per- 
pendicular to each other. This conclusion seems to be 
supported from NMR spectroscopic and X-ray crystallo- 
graphic experiments on the conformational behavior of 
synthetic apsaicin analogues in which the relative disposi- 
tion of the B-section with respect o that of the A-section 
was varied [10]. Based on one of the minimal conforma- 
tions, the structure of compound 37 was optimized, as 
shown in Fig. 6 (01=-32 .84 ,  02= 100.13 and 03= 
- 84.18 degree). Regarding the conformation of the 
diphenyl ether structure, one of the stable conformations in 
which two phenyl rings are perpendicular to each other 
was adopted from the literature [23]. 
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3.5. Comparison o f  inhibitory potency between different 
NDH-1 
The results described above confirmed that capsaicin 
analogues act at the ubiquinone catalytic site of NDH-1. If 
the ubiquinone catalytic sites from different sources share 
similar structural properties, variations among the in- 
hibitory potencies of systematically selected series of in- 
hibitors would correlate well [24,25]. Then, we compared 
the inhibitory potencies in terms of plso, between bovine 
heart and potato tuber mitochondrial NDH-1 (Fig. 7A) and 
between bovine mitochondrial and E. coli NDH-1 (Fig. 
7B). Compounds of which the 150 value could not be 
evaluated ue to limited solubility, were not included in 
the comparison. Correlations among the three enzymes 
were poor, suggesting that the similarity of the structure of 
the ubiquinone catalytic sites in these enzymes is not 
necessarily high. 
In all DB reductase activity measurements described, 
the enzyme reaction was started by the addition of either 
NADH or deaminoNADH. Thus the test compounds made 
contact with the oxidized enzymes, after which their in- 
hibitory actions were determined. Van Belzen et al. [26] 
showed that NADH oxidase activity of bovine heart sub- 
mitochondrial particles was inhibited by piericidin A more 
efficiently in the reduced state than in the oxidized state, 
although a difference was slight. To see whether this is 
also the case for capsaicins, we compared the sensitivity to 
the inhibition by compounds 35 and 39 between reduced 
and oxidized NDH by reversing order of the addition of 
DB and NADH (or deaminoNADH). For the three NDH-1, 
H H H 
H o 
Hl~i~ '" ;~)''-''l'l- ~ H ~ ~  H 
H 
Fig. 6, The optimized conformation f compound 37. The 0 l, 02 and 03 
in Fig. 5 are -32.84, 100.13 and -84.18 degree, respectively. The 
moiety of the molecule corresponding to diphenylether and the 3,4-di- 
methoxy groups on the benzene ring were optimized in isolation. Regard- 
ing the conformation f the diphenylether st ucture, a stable conformation 
in which two phenyl rings are perpendicular to each other was adopted 
from the literature [23]. Two methoxy groups were optimized from 36 
conformers which were obtained by rotation along the MeO-Ph bond in 
steps of 60 ° . 
z 
~s 
3 
3 
• ~quD° o 
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Fig. 7. The relationship between the inhibitory potencies in terms of P/~s0 
determined with different enzymes. (A) The P/s0 determined with bovine 
heart NDH vs. that with potato tuber NDH-I; (B) the plso determined 
with bovine heart NDH vs. that with E. coli NDH-1. 
the sensitivity to the inhibition was almost same irrespec- 
tive of the redox state of the enzymes (data not shown). 
Furthermore, since the inhibitory potencies were treated 
logarithmically, in terms of plso, in this study, a small 
difference, if any, in the sensitivity to other inhibitors 
depending upon the redox state of the enzymes might not 
affect our conclusion. 
4. D iscuss ion  
Capsaicin inhibits NDH-1 activity by acting competi- 
tively against ubiquinone. Considering the structural simi- 
larity between capsaicins and ubiquinone (vicinal methoxy 
groups on the aromatic ring and a hydrophobic alkyl side 
chain), it is reasonable to consider that the spatial position 
occupied by the benzene ring moiety of capsaicin in the 
binding site is superimposed upon that occupied by the 
benzoquinone ring. Therefore, the methoxy groups on the 
benzene ring and their 3,4-substitution pattern were thought 
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to play important roles in inhibitor binding, whereas the 
findings indicated otherwise. It was also indicated that the 
amide bond unit, which can serve as a hydrogen-bond 
donor and acceptor in inhibitor binding, contributes very 
little to the inhibition, particularly for bovine heart and 
potato tuber mitochondrial NDH-1. Thus, the rule regard- 
ing the variation of the inhibitory potency depending upon 
structural modifications is ambiguous. Considering the 
structure-activity studies of several potent electron-trans- 
fer inhibitors (e.g., piericidin derivatives in Ref. [27], 
rotenone derivatives in Ref. [28], stigmatellin derivative in 
Refs. [29,30], methoxyacrylate derivatives in Ref. [31] and 
antimycin derivatives in Refs. [32,33]), in which structural 
modifications of functional group(s) cause drastic changes 
in the activity, the unusual structure-activity profile of the 
capsaicin analogues studied here would be prominent. This 
may be explained assuming that the ubiquinone catalytic 
site of NDH-1 is spacious enough to accommodate a 
variety of structurally different inhibitors in a dissimilar 
manner. Other studies [12,21,34] of the inhibitory mecha- 
nisms of various potent inhibitors of NDH-1 seem to 
support his assumption. It is further notable that the fairly 
high rotational freedom of A- and B-sections of capsaicins 
make these moieties fit flexibly into the large pocket. This 
kind of flexibility also enables the inhibitors to bind to the 
ubiquinone catalytic site in various ways. 
On the other hand, taking into account he fact that 
electrostatic nteractions between the functional groups on 
capsaicins and their binding sites make relatively small 
contributions to their binding, whole molecular shape itself 
might be the significant structural factor supporting tight 
binding. A molecular orbital calculation study suggested 
that a bent form at the face of contact between A- and 
B-sections favors inhibitory action. Regarding the struc- 
turally rigid inhibitor rotenone, Ueno et al. have shown 
that the bent form is important for eliciting the inhibitory 
action [12]. Moreover, a molecular orbital calculation study 
for fenpyroximate indicated that this compound is also 
stable when it takes a bent form (data not shown). To 
confirm whether the bent form is universally required for 
potent inhibitors of NDH- 1, further structure-activity stud- 
ies of other types of potent inhibitors are needed. 
A comparison of variations of inhibitory potency deter- 
mined with NDH-1 from different sources indicated that 
structural similarity of the ubiquinone catalytic site of the 
three NDH-I is rather poor. Contrary to this, since pieri- 
cidin A works as a very potent inhibitor with bovine heart 
and potato tuber mitochondrial NDH-1, and the activity of 
potent inhibitor compound 37 was almost totally retained 
after modifying its functional groups with these two en- 
zymes (37 vs. 41, 44 or 46), the two enzymes may share 
somewhat common structural properties for the ubiquinone 
catalytic site. This apparent inconsistency may be also 
explained by assuming a large ubiquinone catalytic site. 
That is, the ubiquinone catalytic site shares at least a partly 
similar structure that enables the common inhibitors to fit. 
It is notable that structural similarity of the ubiquinone 
catalytic site between bovine heart and potato tuber mito- 
chondrial NDH-1 had been suggested from variations 
among the inhibitory potencies of rotenone stereoisomers 
[12]. Herz et al. [35] have reported that potato tuber 
mitochondrial NDH- 1 is similar in complexity to the bovine 
mitochondrial counterpart and that four of the potato sub- 
units can be aligned by their N-terminal amino acid se- 
quences to corresponding bovine NDH-1 subunits. 
The inhibition pattern of some synthetic apsaicins was 
complicated in bovine heart mitochondrial NDH. It varied 
depending upon the concentration of exogenous quinone. 
A similar complexity has been reported for the inhibition 
by natural capsaicin [7] and synthetic rotenone stereoiso- 
mer [12]. This complicated inhibition profile might be 
interpreted if NDH bears two quinone binding sites with 
the same affinity for quinone, and the activity of this 
enzyme is inhibited by the binding of one molecule of 
inhibitor to one of the two quinone binding sites [7]. In 
other words, although capsaicins in principle bind to the 
quinone binding sites, a noncompetitive inhibition pattern 
might be apparently observed at low levels of quinone 
(DB) since the quinone can be reduced at one of the two 
binding sites which is not occupied by the inhibitor when 
the concentration of quinone is low. Considering the fact 
that two quinone binding sites on mammal mitochondrial 
NDH have been suggested by several groups [1,34,36,37], 
this interpretation seems to be reasonable. The presence of 
endogenous biquinone in submitochondrial particle prepa- 
rations may not affect the kinetics of DB reduction, since 
the reduction of short-chain quinone analogues (as CoQ~ 
and CoQ2) does not involve the endogenous ubiquinone 
[38,39]. In contrast to bovine heart NDH, capsaicins inhib- 
ited the NDH-1 activities of E. coli and potato tuber 
mitochondria n a competitive manner against DB, regard- 
less of their concentrations. Therefore, the concept of two 
quinone binding sites in these enzymes is not supported, at 
least by our observations. 
The sensitivity to inhibition by synthetic capsaicins 
differed remarkably between NDH-I and NDH-2 from 
both potato tuber and E. coli enzymes. Yagi [7,8] has 
indicated that the inhibition by natural capsaicin correlates 
better with the presence of an energy coupling site of 
various NDH than the inhibition by rotenone, piericidin A 
or DCCD. The present study confirmed this notion for a 
variety of synthetic apsaicin analogues. Considering the 
fact that a fairly high concentration f natural capsaicin is 
needed to inhibit NDH-1 activity, it is notable that some 
synthetic analogues can discriminate between NDH-1 and 
NDH-2 much better than natural capsaicin. 
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